This article is part of the supplement: Controversies in Breast Cancer 2009
Are current drug development programmes realising the full potential of new agents? The scenario
-
Correspondence: Stephen RD Johnston stephen.johnston@rmh.nhs.uk
Breast Cancer Research 2009, 11(Suppl 3):S21 doi:10.1186/bcr2440